These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 16805711)
1. Application of encapsulated cell technology for retinal degenerative diseases. Tao W Expert Opin Biol Ther; 2006 Jul; 6(7):717-26. PubMed ID: 16805711 [TBL] [Abstract][Full Text] [Related]
2. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Sieving PA; Caruso RC; Tao W; Coleman HR; Thompson DJ; Fullmer KR; Bush RA Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3896-901. PubMed ID: 16505355 [TBL] [Abstract][Full Text] [Related]
3. Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases. Kauper K; McGovern C; Sherman S; Heatherton P; Rapoza R; Stabila P; Dean B; Lee A; Borges S; Bouchard B; Tao W Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7484-91. PubMed ID: 23049090 [TBL] [Abstract][Full Text] [Related]
4. Ciliary neurotrophic factor (CNTF) delivery to retina: an overview of current research advancements. Ghasemi M; Alizadeh E; Saei Arezoumand K; Fallahi Motlagh B; Zarghami N Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1694-1707. PubMed ID: 29065723 [TBL] [Abstract][Full Text] [Related]
5. On the role of CNTF as a potential therapy for retinal degeneration: Dr. Jekyll or Mr. Hyde? Beltran WA Adv Exp Med Biol; 2008; 613():45-51. PubMed ID: 18188927 [No Abstract] [Full Text] [Related]
6. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Tao W; Wen R; Goddard MB; Sherman SD; O'Rourke PJ; Stabila PF; Bell WJ; Dean BJ; Kauper KA; Budz VA; Tsiaras WG; Acland GM; Pearce-Kelling S; Laties AM; Aguirre GD Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3292-8. PubMed ID: 12356837 [TBL] [Abstract][Full Text] [Related]
7. Preventing blindness in retinal disease: ciliary neurotrophic factor intraocular implants. MacDonald IM; Sauvé Y; Sieving PA Can J Ophthalmol; 2007 Jun; 42(3):399-402. PubMed ID: 17508034 [TBL] [Abstract][Full Text] [Related]
8. Encapsulated cell-based intraocular delivery of ciliary neurotrophic factor in normal rabbit: dose-dependent effects on ERG and retinal histology. Bush RA; Lei B; Tao W; Raz D; Chan CC; Cox TA; Santos-Muffley M; Sieving PA Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2420-30. PubMed ID: 15223826 [TBL] [Abstract][Full Text] [Related]
9. CNTF induces regeneration of cone outer segments in a rat model of retinal degeneration. Li Y; Tao W; Luo L; Huang D; Kauper K; Stabila P; Lavail MM; Laties AM; Wen R PLoS One; 2010 Mar; 5(3):e9495. PubMed ID: 20209167 [TBL] [Abstract][Full Text] [Related]
10. [Neuroprotection of retinal degenerative disease by ciliary neurotrophic factor]. Chen R; Li GL Zhonghua Yan Ke Za Zhi; 2011 Jun; 47(6):568-72. PubMed ID: 21914274 [TBL] [Abstract][Full Text] [Related]
11. CNTF induces dose-dependent alterations in retinal morphology in normal and rcd-1 canine retina. Zeiss CJ; Allore HG; Towle V; Tao W Exp Eye Res; 2006 Mar; 82(3):395-404. PubMed ID: 16143329 [TBL] [Abstract][Full Text] [Related]
12. Retinal Protection by Sustained Nanoparticle Delivery of Oncostatin M and Ciliary Neurotrophic Factor Into Rodent Models of Retinal Degeneration. Yang JY; Lu B; Feng Q; Alfaro JS; Chen PH; Loscalzo J; Wei WB; Zhang YY; Lu SJ; Wang S Transl Vis Sci Technol; 2021 Aug; 10(9):6. PubMed ID: 34347033 [TBL] [Abstract][Full Text] [Related]
13. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Liang FQ; Aleman TS; Dejneka NS; Dudus L; Fisher KJ; Maguire AM; Jacobson SG; Bennett J Mol Ther; 2001 Nov; 4(5):461-72. PubMed ID: 11708883 [TBL] [Abstract][Full Text] [Related]
14. Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications. Booth BA; Vidal Denham L; Bouhanik S; Jacob JT; Hill JM Drugs Aging; 2007; 24(7):581-602. PubMed ID: 17658909 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal injection of ciliary neurotrophic factor (CNTF) causes peripheral remodeling and does not prevent photoreceptor loss in canine RPGR mutant retina. Beltran WA; Wen R; Acland GM; Aguirre GD Exp Eye Res; 2007 Apr; 84(4):753-71. PubMed ID: 17320077 [TBL] [Abstract][Full Text] [Related]
17. Topical instillation of ciliary neurotrophic factor inhibits retinal degeneration in streptozotocin-induced diabetic rats. Aizu Y; Katayama H; Takahama S; Hu J; Nakagawa H; Oyanagi K Neuroreport; 2003 Nov; 14(16):2067-71. PubMed ID: 14600499 [TBL] [Abstract][Full Text] [Related]
18. CNTF Attenuates Vasoproliferative Changes Through Upregulation of SOCS3 in a Mouse-Model of Oxygen-Induced Retinopathy. Bucher F; Walz JM; Bühler A; Aguilar E; Lange C; Diaz-Aguilar S; Martin G; Schlunck G; Agostini H; Friedlander M; Stahl A Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4017-26. PubMed ID: 27494343 [TBL] [Abstract][Full Text] [Related]
19. Sustained Neural Stem Cell-Based Intraocular Delivery of CNTF Attenuates Photoreceptor Loss in the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis. Jankowiak W; Kruszewski K; Flachsbarth K; Skevas C; Richard G; Rüther K; Braulke T; Bartsch U PLoS One; 2015; 10(5):e0127204. PubMed ID: 25992714 [TBL] [Abstract][Full Text] [Related]
20. [Progress in treatment of retinitis pigmentosa by neurotrophic factors]. Zhang X; Li GL Zhonghua Yan Ke Za Zhi; 2009 Sep; 45(9):855-9. PubMed ID: 20137292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]